Kari Gillmeyer, MD, MSc
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Dept of Medicine
Pulmonary, Allergy, Sleep & Critical Care Medicine

MD, University of Minnesota Medical School

Pronouns: she/her/hers



Dr. Gillmeyer is a health services researcher with a career dedicated to improving quality of care and outcomes for vulnerable patients. Dr. Gillmeyer’s work focuses on pulmonary hypertension, a devastating, progressive disease that exerts a heavy burden on patients and health systems. Through her research, Dr. Gillmeyer hopes to improve the quality, safety, and equity of pulmonary hypertension care and to mitigate health disparities in pulmonary hypertension.

Member
Boston University
Pulmonary Center




Characterizing Care Coordination in Pulmonary Hypertension: A Mixed Methods Study
07/01/2021 - 06/30/2024 (PI)
Parker B. Francis Fellowship Program


Determining disparities in treatment of pulmonary arterial hypertension nationally
09/01/2019 - 08/31/2021 (PI)
NIH/National Heart, Lung, and Blood Institute
5F32HL149236-02



Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Johnson SW, Gillmeyer KR, Bolton RE, McCullough MB, Qian SX, Maron BA, Klings ES, Wiener RS. Variable Monitoring of Veterans with Group 3 Pulmonary Hypertension Treated with Off-Label Pulmonary Vasodilator Therapy. Ann Am Thorac Soc. 2022 Jul; 19(7):1236-1239.View Related Profiles. PMID: 35312466; PMCID: PMC9278628; DOI: 10.1513/AnnalsATS.202110-1168RL;
     
  2. Lui JK, Gillmeyer KR, Sangani RA, Smyth RJ, Gopal MDM, Trojanowski MA, Bujor AM, Wiener RS, LaValley MP, Klings ES. A Multimodal Prediction Model for Diagnosing Pulmonary Hypertension in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2022 Jun 09.View Related Profiles. PMID: 35678779; PMCID: PMC9732142; DOI: 10.1002/acr.24969;
     
  3. Rampon G, Jia S, Agrawal R, Arnold N, Martín-Quir?s A, Fischer EA, Malatack J, Jagan N, Sergew A, Case AH, Miller K, Tanios M, Doros G, Ross CS, Garcia MA, Gillmeyer KR, Griffiths NG, Jandali B, Modzelewski KL, Rucci JM, Simpson SQ, Walkey AJ, Bosch NA. Smartphone-Guided Self-prone Positioning vs Usual Care in Nonintubated Hospital Ward Patients With COVID-19: A Pragmatic Randomized Clinical Trial. Chest. 2022 Oct; 162(4):782-791.View Related Profiles. PMID: 35597286; PMCID: PMC9116967; DOI: 10.1016/j.chest.2022.05.009;
     
  4. Garcia MA, Rampon GL, Doros G, Jia S, Jagan N, Gillmeyer K, Berical A, Hudspeth J, Ieong M, Modzelewski KL, Schechter-Perkins EM, Ross CS, Rucci JM, Simpson S, Walkey AJ, Bosch NA. Rationale and Design of the Awake Prone Position for Early Hypoxemia in COVID-19 Study Protocol: A Clinical Trial. Ann Am Thorac Soc. 2021 09; 18(9):1560-1566.View Related Profiles. PMID: 33647225; PMCID: PMC8489858; DOI: 10.1513/AnnalsATS.202009-1124SD;
     
  5. Gillmeyer KR, Miller DR, Glickman ME, Qian SX, Klings ES, Maron BA, Hanlon JT, Rinne ST, Wiener RS. Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease. Pulm Circ. 2021 Apr-Jun; 11(2):20458940211001714.View Related Profiles. PMID: 33868640; PMCID: PMC8020250; DOI: 10.1177/20458940211001714;
     
  6. Gillmeyer KR, Nunez ER, Rinne ST, Qian SX, Klings ES, Wiener RS. Development and Validation of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data. Chest. 2021 05; 159(5):1986-1994.View Related Profiles. PMID: 33345949; PMCID: PMC8129727; DOI: 10.1016/j.chest.2020.12.010;
     
  7. Lui JK, Bosch NA, Gillmeyer KR, Reardon CC. Novel Therapeutic Approaches for Pulmonary Manifestations of Systemic Sclerosis. Am J Respir Crit Care Med. 2020 09 15; 202(6):878-880.View Related Profiles. PMID: 32574505; PMCID: PMC7491395; DOI: 10.1164/rccm.202002-0307RR;
     
  8. Gillmeyer KR, Rinne ST, Walkey AJ, Qian SX, Wiener RS. How Closely Do Clinical Trial Participants Resemble "Real-World" Patients with Groups 2 and 3 Pulmonary Hypertension? A Structured Review. Ann Am Thorac Soc. 2020 06; 17(6):779-783.View Related Profiles. PMID: 32150687; PMCID: PMC7258417; DOI: 10.1513/AnnalsATS.202001-003RL;
     
  9. Gillmeyer KR, Rinne ST, Glickman ME, Lee KM, Shao Q, Qian SX, Klings ES, Maron BA, Hanlon JT, Miller DR, Wiener RS. Factors Associated With Potentially Inappropriate Phosphodiesterase-5 Inhibitor Use for Pulmonary Hypertension in the United States, 2006 to 2015. Circ Cardiovasc Qual Outcomes. 2020 05; 13(5):e005993.View Related Profiles. PMID: 32393128; PMCID: PMC7344878; DOI: 10.1161/CIRCOUTCOMES.119.005993;
     
  10. Gillmeyer KR, Lee KM, Shao Q, Miller DR, Maron BA, Klings ES, Rinne ST, Wiener RS. Multisystem Healthcare Use among U.S. Veterans with Pulmonary Hypertension. Ann Am Thorac Soc. 2019 08; 16(8):1072-1074.View Related Profiles. PMID: 31026406; PMCID: PMC6774747; DOI: 10.1513/AnnalsATS.201902-109RL;
     
Showing 10 of 12 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 12 publications over 5 distinct years, with a maximum of 4 publications in 2020

YearPublications
20181
20192
20204
20212
20223


2021-2024 Parker B Francis Fellowship Award
2019-2021 F32 HL149236-01: Determining disparities in treatment of pulmonary arterial hypertension nationally
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Pulmonary hypertension
Health disparities
Care organization
Care delivery
Health services research
Contact for Mentoring:

72 E. Concord Street
Boston MA 02118
Google Map

617.358.2800
Download vCard

Gillmeyer's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (55) concept(s)
_
Co-Authors
See all (22) people
_
Similar People
See all (60) people
_
Same Department
Search Department